Bioceres Crop Solutions Corp (BIOX) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results

Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million Bioceres Crop Solutions Corp...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter...

Bioceres Crop Solutions to Host Fiscal Second Quarter 2025 Financial Results Conference Call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form F-3/A - Registration statement by foreign private issuers: [Amend]

Form F-3 - Registration statement by foreign private issuers

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]